United Therapeutics (UTHR) Tops Q1 EPS by $1.69
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $510.38 --0%
EPS Growth %: -10.1%
Financial Fact:
Income tax expense: -77.3M
Today's EPS Names:
PMCB, PLCE, DOMO, More
EPS Growth %: -10.1%
Financial Fact:
Income tax expense: -77.3M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $5.03, $1.69 better than the analyst estimate of $3.34. Revenue for the quarter came in at $461.9 million versus the consensus estimate of $420.02 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic jumps on earnings beat and raised guidance
- Profound Medical names Richard Fabian as president
- United Therapeutics Presents Data at The European Society of Cardiology Congress 2026 and The European Respiratory Society International Congress 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
